Antisense Therapeutics Limited

ASX:ANP ISIN:AU000000ANP4

The development of novel antisense pharmaceuticals for commercially important human conditions. 
 

News

ANTISENSE THERAPEUTICS LIMITED ASX: ANP - Commencement of Phase IIa Multiple Sclerosis Trial - Mr Mark Diamond, CEO

🕔6/29/2006 1:13:00 PM 1417

ANTISENSE THERAPEUTICS LIMITED (ASX: ANP) - Commencement of Phase IIa Multiple Sclerosis Trial - Mr Mark Diamond, CEO; Boardroomradio is pleased to announce that ANTISENSE THERAPEUTICS LIMITED (ASX: ANP) has published an audio file.

Read Full Article▸
###

611 COMPANY PROFILE VIEWS

  • This Page Viewed: (Last 30 Days: 6) (Since Published: 611) 

Company Data

    Fax
  • (03) 9827 1166 
    • Principal Sector
  • Health & Pharm 
    • Principal Industry
  • Biotechnology 
    • Listed
  • 2001/12/20 
    • Homepage
  • www.antisense.com.au/